Pharmacological differences between human and guinea pig histamine H1 receptors:: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor

被引:42
作者
Bruysters, M
Jongejan, A
Gillard, M
van de Manakker, F
Bakker, RA
Chatelain, P
Leurs, R
机构
[1] Free Univ Amsterdam, Fac Sci, Dept Med Chem, Leiden Amsterdam Ctr Drug Res, NL-1081 BT Amsterdam, Netherlands
[2] UCB Bioprod SA, Pharma Sector, Braine LAlleud, Belgium
关键词
D O I
10.1124/mol.104.008847
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We tested several histamine H-1 receptor (H1R) agonists and antagonists for their differences in binding affinities between human and guinea pig H(1)Rs transiently expressed in African green monkey kidney ( COS-7) cells. Especially, the bivalent agonist histaprodifen-histamine dimer (HP-HA) shows a higher affinity for guinea pig than for human H(1)Rs. Based on the structure of HP-HA, we have further identified VUF 4669 [7-(3-(4-(hydroxydiphenylmethyl)piperidin-1-yl)propoxy)-4-oxochroman-2-carboxylic acid] as a guinea pig-preferring H1R antagonist, demonstrating that the concept of species selectivity is not limited to agonists. To delineate the molecular mechanisms behind the observed species selectivity, we have created mutant human H(1)Rs in which amino acids were individually replaced by their guinea pig H1R counterparts. Residue Asn84 (2.61) in transmembrane domain (TM) 2 seemed to act as a selectivity switch in the H1R. Molecular modeling and site-directed mutagenesis studies suggest that Asn84 interacts with the conserved Tyr(458) (7.43) in TM7. Our data provide the first evidence that for some H1R ligands, the binding pocket is not only limited to TMs 3, 4, 5, and 6 but also comprises an additional pocket formed by TMs 2 and 7.
引用
收藏
页码:1045 / 1052
页数:8
相关论文
共 35 条
[1]   8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist [J].
Bakker, RA ;
Weiner, DM ;
ter Laak, T ;
Beuming, T ;
Zuiderveld, OP ;
Edelbroek, M ;
Hacksell, U ;
Timmerman, H ;
Brann, MR ;
Leurs, R .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :538-549
[2]   Histamine H1-receptor activation of nuclear factor-κB:: Roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling [J].
Bakker, RA ;
Schoonus, SBJ ;
Smit, MJ ;
Timmerman, H ;
Leurs, R .
MOLECULAR PHARMACOLOGY, 2001, 60 (05) :1133-1142
[3]  
Ballesteros JA, 1995, Methods Neurosci, V25, P366, DOI [DOI 10.1016/S1043-9471(05)80049-7, 10.1016/S1043-9471(05)80049-7]
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens [J].
Bruysters, M ;
Pertz, HH ;
Teunissen, A ;
Bakker, RA ;
Gillard, M ;
Chatelain, P ;
Schunack, W ;
Timmerman, H ;
Leurs, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 487 (1-3) :55-63
[6]   A graph-theory algorithm for rapid protein side-chain prediction [J].
Canutescu, AA ;
Shelenkov, AA ;
Dunbrack, RL .
PROTEIN SCIENCE, 2003, 12 (09) :2001-2014
[7]   Histamine H1-agonist properties of histaprodifen derivatives on guinea-pig isolated trachea and ileum [J].
Chrisophe, B ;
Carlier, B ;
Schunack, W ;
Chatelain, P ;
Peck, MJ ;
Massingham, R .
INFLAMMATION RESEARCH, 2003, 52 (Suppl 1) :S51-S52
[8]   Histaprodifens:: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H1-receptor agonists [J].
Elz, S ;
Kramer, K ;
Pertz, HH ;
Detert, H ;
ter Laak, AM ;
Kühne, R ;
Schunack, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1071-1084
[9]   MOLECULAR-CLONING OF THE HUMAN HISTAMINE H1 RECEPTOR GENE [J].
FUKUI, H ;
FUJIMOTO, K ;
MIZUGUCHI, H ;
SAKAMOTO, K ;
HORIO, Y ;
TAKAI, S ;
YAMADA, K ;
ITO, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (02) :894-901
[10]   Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors:: Contribution of Lys191 and Thr194 [J].
Gillard, M ;
Van Der Perren, C ;
Moguilevsky, N ;
Massingham, R ;
Chatelain, P .
MOLECULAR PHARMACOLOGY, 2002, 61 (02) :391-399